1-3 of 3
Helen M Parry
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact of Pausing Bruton Tyrosine Kinase Inhibitor Therapy and Responsiveness of Vaccination in Blood Cancer Patients: Primary Outcome Result for the Randomised Improve Trial

Piers Patten, Jonathan Cook, Nicholas Peckham, Paul Moss, Neil Phillips, Abhishek Abhishek, Thomas Roberts, Georgina Talbot, Vicki Barber, Anne Francis, Fiona Ashford, Lelia Duley, Robbert Hoogeboom, Brian Willett, Nilima Parry-Jones, Toby A. Eyre, Farooq Ahmad Wandroo, Claire Hutchinson, Duncan James Murray, Gratian Vandici, Nicolas Martinez-Calle, Stephen Jenkins, Helen M Parry
Journal: Blood
Blood (2023) 142 (Supplement 1): 1904.
https://doi.org/10.1182/blood-2023-188725
Published: 2023
Journal Articles

Primary CLL Xenograft: A Model System to Study the Role of T-Cells in CLL Biology and Therapeutic Response

Ceri E Oldreive, PhD, Anna Skowronska, PhD, Angelo Agathanggelou, PhD, Helen M Parry, Sergey Krysov, Graham K Packham, PhD, Rudzki Zbgniew, Guy Pratt, A. Malcolm R Taylor, PhD, Paul Moss, MDPhD, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3284.
https://doi.org/10.1182/blood.V124.21.3284.3284
Published: 2014
Journal Articles

CLL Is Associated with Development of Subclinical Cytomegalovirus Viraemia and Accumulation of Large Populations of “exhausted” CMV-Specific CD4+ T Cells

Helen M Parry, Natasha Cutmore, Nikhil Mirajkar, Annette Pachnio, Tina McSkeane, Miriam Ciaurriz, Duncan Baird, Chris Pepper, Mike Griffiths, Guy Pratt, Paul Moss, MDPhD
Journal: Blood
Blood (2014) 124 (21): 3290.
https://doi.org/10.1182/blood.V124.21.3290.3290
Published: 2014